PlainPharmaWatch

CMS Open Payments · Program Year 2024

Rock Medical Orthopedics, Inc.

Rock Medical Orthopedics, Inc. reported $23,508.00 across General Payments, Research, and Ownership to 248 physicians and teaching hospitals across 248 transactions.

$23.5K Below-median payer
All-tracks total
248 Above-median volume
Transactions
248 Above-median reach
Recipients
−$9.6K
General Payments vs PY2023

Rock Medical Orthopedics, Inc. reported $23,508.00 across all CMS Open Payments tracks (General + Research + Ownership) to 248 physicians and teaching hospitals in Program Year 2024 - ranking #1509 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $23,508.00, averaging $94.79 per recipient.

How Rock Medical Orthopedics, Inc.'s $23.5K all-tracks total breaks down

Rock Medical Orthopedics, Inc.'s payment reach score

Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.

Overall reach score

F

14/100

Total payments

F

10/100

Transaction volume

F

12/100

Physician reach

F

12/100

Payment type diversity

F

23/100

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

CMS Sunshine Act warrant

Manufacturer rock-medical-orthopedics-inc Rock Medical Orthopedics, Inc.

$23.5K · #1509/1,925 · 0.0% industry · PY2024

  • TOT $23.5K
  • RANK #1509
  • SHARE 0.0%
  • TXN 248
  • RCP 248
  • CAT 2
  • GEN $23.5K
  • ΔGEN −$9.6K
  • TOP1 4.6%
  • PY 2024

Nearest volume peer: Biodynamik, Inc ($23.6K)

Heru, Inc.$23.8KPrimo Medical Group, Inc. (f…$23.8KAir Techniques, Inc.$23.7KBiodynamik, Inc$23.6KRock Medical Orthopedics, In…$23.5K
All-tracks payment totals near Rock Medical Orthopedics, Inc. (CMS Open Payments PY2024)

Rock Medical Orthopedics, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

Release-over-release change

General Payments changed from PY2023 to PY2024

Rock Medical Orthopedics, Inc.'s CMS-reported General Payments decreased by $9.6K (−29.0%) from PY2023 to PY2024.

How this year-over-year comparison is scoped

The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.

CMS source labels for this exact identifier: PY2022: ROCK MEDICAL ORTHOPEDICS, INC.PY2023: ROCK MEDICAL ORTHOPEDICS, INC.PY2024: Rock Medical Orthopedics, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$33.1KPY2024$23.5K
PY2023
$33,109.15
PY2024
$23,508.00

What the Data Shows for Rock Medical Orthopedics, Inc.

The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For Rock Medical Orthopedics, Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.

The 2-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Travel and Lodging" at $11.9K, accounting for 50.6% of this company's General Payments and 35 transactions.

General Payment Breakdown by Type

"Travel and Lodging" leads Rock Medical Orthopedics, Inc.'s 2-category general-payment breakdown at $11.9K, 50.6% of the reported total.

How Rock Medical Orthopedics, Inc. divides its payments

How the reported total splits across payment categories

1. Travel and Lodging$11.9K2. Food and Beverage$11.6K
Payment Type Amount Transactions
Travel and Lodging $11.9K 35
Food and Beverage $11.6K 213

Recipient Concentration in General Payments

The five largest recipient relationships account for $4,286.95 (18.2%) of $23,508.00 in this company's General Payments records across 165 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Rock Medical Orthopedics, Inc.

The five named recipients with the highest reported General Payments from this company

Skylar Fankhauser$1.1KJacob Calcei$962.83Scott Mollison$824.10Nathan Rech$711.42Emily Exten$703.42
  1. 1

    Skylar Fankhauser

    $1,085.18 across 5 reported transactions

  2. 2

    Jacob Calcei

    $962.83 across 3 reported transactions

  3. 3

    Scott Mollison

    $824.10 across 4 reported transactions

  4. 4

    Nathan Rech

    $711.42 across 3 reported transactions

  5. 5

    Emily Exten

    $703.42 across 4 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Spend vs. Concentration

Rock Medical Orthopedics, Inc.'s spend rank (#1509 of 1,925, bottom 22% by spend) and concentration rank (#1,568 of 1,838, bottom 15% least concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.

01.83.75.57.3182.2186.6191195.4199.8Total payments ($M)Concentration (HHI, 0-10,000)
Rock Medical Orthopedics, Inc. (highlighted) among its 12 nearest HHI-concentration neighbors, Program Year 2024. Dashed lines mark this neighborhood's median payment total and median HHI. Hover a point for the company name. Source: company_concentration (CMS Open Payments general-payment recipients).
View all 12 companies in this HHI neighborhood as a list

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Rock Medical Orthopedics, Inc.'s, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Rock Medical Orthopedics, Inc..

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Rock Medical Orthopedics, Inc..

Showing 6 of 1,924 companies with CMS-reported payment data.

Put this to use

Rock Medical Orthopedics, Inc. ranks #1509 of 1,925 by all-tracks total payments, led by "Travel and Lodging".

Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

View saved (companies)
Download Rock Medical Orthopedics, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.